REPORT ID 2256

Global Chemotherapy Induced Anemia Drug Market Research Report 2017

Publish Date
8-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the global Chemotherapy Induced Anemia Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chemotherapy Induced Anemia Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Chemotherapy Induced Anemia Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    3SBio Inc.
    BIOCAD
    Chong Kun Dang Pharmaceutical Corp.
    Dr. Reddy's Laboratories Limited
    Galenica Ltd.
    Panacea Biotec Limited
    Pfizer Inc.
    PharmaEssentia Corporation
    PhytoHealth Corporation
    Pieris Pharmaceuticals Inc
    Sandoz International GmbH
    SBI Pharmaceuticals Co., Ltd.
    Therapure Biopharma Inc.
    Tolero Pharmaceuticals, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Epoetin Zeta Biosimilar
    Ferric Carboxymaltose
    Pegylated Erythropoietin
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Homecare

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Chemotherapy Induced Anemia Drug Market Research Report 2017
1 Chemotherapy Induced Anemia Drug Market Overview
    1.1 Product Overview and Scope of Chemotherapy Induced Anemia Drug
    1.2 Chemotherapy Induced Anemia Drug Segment by Type (Product Category)
        1.2.1 Global Chemotherapy Induced Anemia Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Chemotherapy Induced Anemia Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Epoetin Zeta Biosimilar
        1.2.4 Ferric Carboxymaltose
        1.2.5 Pegylated Erythropoietin
        1.2.6 Others
    1.3 Global Chemotherapy Induced Anemia Drug Segment by Application
        1.3.1 Chemotherapy Induced Anemia Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Homecare
    1.4 Global Chemotherapy Induced Anemia Drug Market by Region (2012-2022)
        1.4.1 Global Chemotherapy Induced Anemia Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Chemotherapy Induced Anemia Drug (2012-2022)
        1.5.1 Global Chemotherapy Induced Anemia Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Chemotherapy Induced Anemia Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Chemotherapy Induced Anemia Drug Market Competition by Manufacturers
    2.1 Global Chemotherapy Induced Anemia Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Chemotherapy Induced Anemia Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Chemotherapy Induced Anemia Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Chemotherapy Induced Anemia Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Chemotherapy Induced Anemia Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Chemotherapy Induced Anemia Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Chemotherapy Induced Anemia Drug Market Competitive Situation and Trends
        2.5.1 Chemotherapy Induced Anemia Drug Market Concentration Rate
        2.5.2 Chemotherapy Induced Anemia Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Chemotherapy Induced Anemia Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Chemotherapy Induced Anemia Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Chemotherapy Induced Anemia Drug Production and Market Share by Region (2012-2017)
    3.3 Global Chemotherapy Induced Anemia Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Chemotherapy Induced Anemia Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Chemotherapy Induced Anemia Drug Consumption by Region (2012-2017)
    4.2 North America Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Chemotherapy Induced Anemia Drug Production, Consumption, Export, Import (2012-2017)

5 Global Chemotherapy Induced Anemia Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Chemotherapy Induced Anemia Drug Production and Market Share by Type (2012-2017)
    5.2 Global Chemotherapy Induced Anemia Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Chemotherapy Induced Anemia Drug Price by Type (2012-2017)
    5.4 Global Chemotherapy Induced Anemia Drug Production Growth by Type (2012-2017)

6 Global Chemotherapy Induced Anemia Drug Market Analysis by Application
    6.1 Global Chemotherapy Induced Anemia Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Chemotherapy Induced Anemia Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Chemotherapy Induced Anemia Drug Manufacturers Profiles/Analysis
    7.1 3SBio Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 3SBio Inc. Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 BIOCAD
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 BIOCAD Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Chong Kun Dang Pharmaceutical Corp.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Dr. Reddy's Laboratories Limited
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Galenica Ltd.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Galenica Ltd. Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Panacea Biotec Limited
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Pfizer Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Pfizer Inc. Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 PharmaEssentia Corporation
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 PhytoHealth Corporation
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Pieris Pharmaceuticals Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Chemotherapy Induced Anemia Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Sandoz International GmbH
    7.12 SBI Pharmaceuticals Co., Ltd.
    7.13 Therapure Biopharma Inc.
    7.14 Tolero Pharmaceuticals, Inc.

8 Chemotherapy Induced Anemia Drug Manufacturing Cost Analysis
    8.1 Chemotherapy Induced Anemia Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Chemotherapy Induced Anemia Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Chemotherapy Induced Anemia Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Chemotherapy Induced Anemia Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Chemotherapy Induced Anemia Drug Market Forecast (2017-2022)
    12.1 Global Chemotherapy Induced Anemia Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Chemotherapy Induced Anemia Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Chemotherapy Induced Anemia Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Chemotherapy Induced Anemia Drug Price and Trend Forecast (2017-2022)
    12.2 Global Chemotherapy Induced Anemia Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Chemotherapy Induced Anemia Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Chemotherapy Induced Anemia Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Chemotherapy Induced Anemia Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer